Skip to main content

Volume 9 Supplement 2

Controversies in breast cancer

Short communications

Edited by William R Miller, Lesley J Fallowfield, Mitch Dowsett, Richard J Santen, James N Ingle

The Symposium and supplement were supported by unrestricted educational grants from AstraZeneca, Novartis, Pfizer and Roche

Controversies in Breast Cancer 2007.

Edinburgh, UK3-4 September 2007

Annual Journal Metrics

  • 2022 Citation Impact
    7.4 - 2-year Impact Factor
    7.4 - 5-year Impact Factor
    1.764 - SNIP (Source Normalized Impact per Paper)
    2.408 - SJR (SCImago Journal Rank)

    2022 Speed
    27 days submission to first editorial decision for all manuscripts (Median)
    166 days submission to accept (Median)

    2022 Usage 
    8,627 Altmetric mentions